These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 30912586)
1. Synthesis and preliminary radiopharmacological characterisation of an Laube M; Frizler M; Wodtke R; Neuber C; Belter B; Kniess T; Bachmann M; Gütschow M; Pietzsch J; Löser R J Labelled Comp Radiopharm; 2019 Jun; 62(8):448-459. PubMed ID: 30912586 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and radiopharmacological characterisation of a fluorine-18-labelled azadipeptide nitrile as a potential PET tracer for in vivo imaging of cysteine cathepsins. Löser R; Bergmann R; Frizler M; Mosch B; Dombrowski L; Kuchar M; Steinbach J; Gütschow M; Pietzsch J ChemMedChem; 2013 Aug; 8(8):1330-44. PubMed ID: 23785011 [TBL] [Abstract][Full Text] [Related]
3. Fluorescent nitrile-based inhibitors of cysteine cathepsins. Frizler M; Mertens MD; Gütschow M Bioorg Med Chem Lett; 2012 Dec; 22(24):7715-8. PubMed ID: 23122525 [TBL] [Abstract][Full Text] [Related]
4. Selective nitrile inhibitors to modulate the proteolytic synergism of cathepsins S and F. Frizler M; Schmitz J; Schulz-Fincke AC; Gütschow M J Med Chem; 2012 Jun; 55(12):5982-6. PubMed ID: 22686657 [TBL] [Abstract][Full Text] [Related]
5. Impact of structural alterations on the radiopharmacological profile of Tietz O; Marshall A; Bergman C; Wuest M; Wuest F Nucl Med Biol; 2018; 62-63():9-17. PubMed ID: 29800798 [TBL] [Abstract][Full Text] [Related]
6. Highly selective azadipeptide nitrile inhibitors for cathepsin K: design, synthesis and activity assays. Ren XF; Li HW; Fang X; Wu Y; Wang L; Zou S Org Biomol Chem; 2013 Feb; 11(7):1143-8. PubMed ID: 23299878 [TBL] [Abstract][Full Text] [Related]
8. Structural optimization of azadipeptide nitriles strongly increases association rates and allows the development of selective cathepsin inhibitors. Frizler M; Lohr F; Furtmann N; Kläs J; Gütschow M J Med Chem; 2011 Jan; 54(1):396-400. PubMed ID: 21128614 [TBL] [Abstract][Full Text] [Related]
9. Active Site Mapping of Human Cathepsin F with Dipeptide Nitrile Inhibitors. Schmitz J; Furtmann N; Ponert M; Frizler M; Löser R; Bartz U; Bajorath J; Gütschow M ChemMedChem; 2015 Aug; 10(8):1365-77. PubMed ID: 26119278 [TBL] [Abstract][Full Text] [Related]
10. Development of nitrile-based peptidic inhibitors of cysteine cathepsins. Frizler M; Stirnberg M; Sisay MT; Gütschow M Curr Top Med Chem; 2010; 10(3):294-322. PubMed ID: 20166952 [TBL] [Abstract][Full Text] [Related]
11. Dipeptide-Derived Alkynes as Potent and Selective Irreversible Inhibitors of Cysteine Cathepsins. Behring L; Ruiz-Gómez G; Trapp C; Morales M; Wodtke R; Köckerling M; Kopka K; Pisabarro MT; Pietzsch J; Löser R J Med Chem; 2023 Mar; 66(6):3818-3851. PubMed ID: 36867428 [TBL] [Abstract][Full Text] [Related]
12. Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L. Falgueyret JP; Oballa RM; Okamoto O; Wesolowski G; Aubin Y; Rydzewski RM; Prasit P; Riendeau D; Rodan SB; Percival MD J Med Chem; 2001 Jan; 44(1):94-104. PubMed ID: 11141092 [TBL] [Abstract][Full Text] [Related]
13. Non-invasive imaging of cysteine cathepsin activity in solid tumors using a 64Cu-labeled activity-based probe. Ren G; Blum G; Verdoes M; Liu H; Syed S; Edgington LE; Gheysens O; Miao Z; Jiang H; Gambhir SS; Bogyo M; Cheng Z PLoS One; 2011; 6(11):e28029. PubMed ID: 22132198 [TBL] [Abstract][Full Text] [Related]
14. Dipeptide nitrile inhibitors of cathepsin K. Altmann E; Aichholz R; Betschart C; Buhl T; Green J; Lattmann R; Missbach M Bioorg Med Chem Lett; 2006 May; 16(9):2549-54. PubMed ID: 16480867 [TBL] [Abstract][Full Text] [Related]
15. Interaction of papain-like cysteine proteases with dipeptide-derived nitriles. Löser R; Schilling K; Dimmig E; Gütschow M J Med Chem; 2005 Dec; 48(24):7688-707. PubMed ID: 16302809 [TBL] [Abstract][Full Text] [Related]
16. Fluorine-18 radiolabeling and radiopharmacological characterization of a benzodioxolylpyrimidine-based radiotracer targeting the receptor tyrosine kinase EphB4. Mamat C; Mosch B; Neuber C; Köckerling M; Bergmann R; Pietzsch J ChemMedChem; 2012 Nov; 7(11):1991-2003. PubMed ID: 23042640 [TBL] [Abstract][Full Text] [Related]
17. S-11C-methyl-L-cysteine: a new amino acid PET tracer for cancer imaging. Deng H; Tang X; Wang H; Tang G; Wen F; Shi X; Yi C; Wu K; Meng Q J Nucl Med; 2011 Feb; 52(2):287-93. PubMed ID: 21233188 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and preclinical evaluation of [(11)C]PAQ as a PET imaging tracer for VEGFR-2. Samén E; Thorell JO; Lu L; Tegnebratt T; Holmgren L; Stone-Elander S Eur J Nucl Med Mol Imaging; 2009 Aug; 36(8):1283-95. PubMed ID: 19288096 [TBL] [Abstract][Full Text] [Related]
19. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer. Wuest M; Trayner BJ; Grant TN; Jans HS; Mercer JR; Murray D; West FG; McEwan AJ; Wuest F; Cheeseman CI Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283 [TBL] [Abstract][Full Text] [Related]
20. Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design. Greenspan PD; Clark KL; Tommasi RA; Cowen SD; McQuire LW; Farley DL; van Duzer JH; Goldberg RL; Zhou H; Du Z; Fitt JJ; Coppa DE; Fang Z; Macchia W; Zhu L; Capparelli MP; Goldstein R; Wigg AM; Doughty JR; Bohacek RS; Knap AK J Med Chem; 2001 Dec; 44(26):4524-34. PubMed ID: 11741472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]